ID: ALA5283866

Max Phase: Preclinical

Molecular Formula: C25H43N15O6S

Molecular Weight: 681.79

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCC[C@H](N)C(=O)NCC(=O)N[C@H](CCNC(=N)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O

Standard InChI:  InChI=1S/C25H43N15O6S/c26-12(2-1-4-32-24(29)30)22(45)35-8-15(41)39-13(20(28)44)3-5-33-25(31)34-6-7-47-9-14-17(42)18(43)23(46-14)40-11-38-16-19(27)36-10-37-21(16)40/h10-14,17-18,23,42-43H,1-9,26H2,(H2,28,44)(H,35,45)(H,39,41)(H2,27,36,37)(H4,29,30,32)(H3,31,33,34)/t12-,13+,14+,17+,18+,23+/m0/s1

Standard InChI Key:  CDHNSYFOBQQCHE-GBXCTRARSA-N

Associated Targets(Human)

PRMT5 Tchem Protein arginine N-methyltransferase 5 (1273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRMT1 Tchem Protein-arginine N-methyltransferase 1 (867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CARM1 Tchem Histone-arginine methyltransferase CARM1 (564 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 681.79Molecular Weight (Monoisotopic): 681.3241AlogP: -5.06#Rotatable Bonds: 18
Polar Surface Area: 356.43Molecular Species: BASEHBA: 15HBD: 13
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.08CX Basic pKa: 12.07CX LogP: -6.13CX LogD: -11.47
Aromatic Rings: 2Heavy Atoms: 47QED Weighted: 0.04Np Likeness Score: 0.31

References

1. Fu S, Zheng Q, Zhang D, Lin C, Ouyang L, Zhang J, Chen L..  (2022)  Medicinal chemistry strategies targeting PRMT5 for cancer therapy.,  244  [PMID:36274274] [10.1016/j.ejmech.2022.114842]

Source